GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GRAL is expected to report earnings to rise 63.01% to -401 cents per share on February 19
Q4'25
Est.
$-4.01
Q3'25
Beat
by $1.53
Q2'25
Beat
by $0.94
Q1'25
Beat
by $1.16
The last earnings report on November 12 showed earnings per share of -246 cents, beating the estimate of -399 cents. With 1.23M shares outstanding, the current market capitalization sits at 3.94B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GRAL showed earnings on November 12, 2025. You can read more about the earnings report here.